CORBION NV (CRBN.AS) Stock Fundamental Analysis
Europe - Euronext Amsterdam - AMS:CRBN - NL0010583399 - Common Stock
18.27 EUR
-0.04 (-0.22%)
We assign a fundamental rating of 5 out of 10 to CRBN. CRBN was compared to 72 industry peers in the Chemicals industry. CRBN has only an average score on both its financial health and profitability. CRBN is cheap, but on the other hand it scores bad on growth. These ratings would make CRBN suitable for value investing!
1. Profitability
1.1 Basic Checks
CRBN had positive earnings in the past year.
In the past year CRBN had a positive cash flow from operations.
Each year in the past 5 years CRBN has been profitable.
CRBN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 4.55%, CRBN is doing good in the industry, outperforming 68.06% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.12%, CRBN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CRBN has a Return On Invested Capital of 9.19%. This is in the better half of the industry: CRBN outperforms 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 7.08%.
The last Return On Invested Capital (9.19%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROIC | 9.19% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
1.3 Margins
Looking at the Profit Margin, with a value of 5.11%, CRBN is in the better half of the industry, outperforming 63.89% of the companies in the same industry.
In the last couple of years the Profit Margin of CRBN has grown nicely.
Looking at the Operating Margin, with a value of 8.68%, CRBN is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
CRBN's Operating Margin has declined in the last couple of years.
CRBN's Gross Margin of 26.10% is on the low side compared to the rest of the industry. CRBN is outperformed by 63.89% of its industry peers.
CRBN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% |
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRBN is still creating some value.
Compared to 1 year ago, CRBN has less shares outstanding
The number of shares outstanding for CRBN has been reduced compared to 5 years ago.
CRBN has a better debt/assets ratio than last year.
2.2 Solvency
CRBN has an Altman-Z score of 2.73. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.73, CRBN perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
CRBN has a debt to FCF ratio of 4.95. This is a neutral value as CRBN would need 4.95 years to pay back of all of its debts.
The Debt to FCF ratio of CRBN (4.95) is better than 70.83% of its industry peers.
A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
CRBN has a Debt to Equity ratio (0.39) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Altman-Z | 2.73 |
ROIC/WACC1.45
WACC6.36%
2.3 Liquidity
CRBN has a Current Ratio of 1.21. This is a normal value and indicates that CRBN is financially healthy and should not expect problems in meeting its short term obligations.
CRBN has a Current ratio of 1.21. This is amonst the worse of the industry: CRBN underperforms 81.94% of its industry peers.
A Quick Ratio of 0.60 indicates that CRBN may have some problems paying its short term obligations.
The Quick ratio of CRBN (0.60) is worse than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
CRBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.99%.
Measured over the past years, CRBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 49.47% on average per year.
CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.95%.
CRBN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.70% yearly.
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
3.2 Future
CRBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.24% yearly.
The Revenue is expected to decrease by -1.71% on average over the next years.
EPS Next Y36.6%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
EPS Next 5Y15.24%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.31, which indicates a correct valuation of CRBN.
Based on the Price/Earnings ratio, CRBN is valued a bit cheaper than 73.61% of the companies in the same industry.
CRBN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 12.01 indicates a correct valuation of CRBN.
Based on the Price/Forward Earnings ratio, CRBN is valued a bit cheaper than the industry average as 76.39% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CRBN to the average of the S&P500 Index (23.56), we can say CRBN is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.31 | ||
| Fwd PE | 12.01 |
4.2 Price Multiples
CRBN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 66.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CRBN is valued cheaper than 93.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.66 | ||
| EV/EBITDA | 7.71 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRBN has a very decent profitability rating, which may justify a higher PE ratio.
CRBN's earnings are expected to grow with 19.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)0.33
EPS Next 2Y22.97%
EPS Next 3Y19.62%
5. Dividend
5.1 Amount
CRBN has a Yearly Dividend Yield of 3.47%.
Compared to an average industry Dividend Yield of 3.19, CRBN pays a bit more dividend than its industry peers.
CRBN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.47% |
5.2 History
The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
5.3 Sustainability
56.19% of the earnings are spent on dividend by CRBN. This is a bit on the high side, but may be sustainable.
The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.19%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
AMS:CRBN (12/9/2025, 5:29:47 PM)
18.27
-0.04 (-0.22%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners90.59%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.06B
Revenue(TTM)1.30B
Net Income(TTM)66.20M
Analysts78.57
Price Target23.92 (30.93%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.47% |
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.19%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.96%
PT rev (3m)2.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)-1.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.31 | ||
| Fwd PE | 12.01 | ||
| P/S | 0.82 | ||
| P/FCF | 10.66 | ||
| P/OCF | 6.32 | ||
| P/B | 1.47 | ||
| P/tB | 1.68 | ||
| EV/EBITDA | 7.71 |
EPS(TTM)1.12
EY6.13%
EPS(NY)1.52
Fwd EY8.33%
FCF(TTM)1.71
FCFY9.38%
OCF(TTM)2.89
OCFY15.83%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.45
PEG (5Y)0.33
Graham Number17.72
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| ROCE | 10.92% | ||
| ROIC | 9.19% | ||
| ROICexc | 9.57% | ||
| ROICexgc | 10.55% | ||
| OM | 8.68% | ||
| PM (TTM) | 5.11% | ||
| GM | 26.1% | ||
| FCFM | 7.7% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 4.95 | ||
| Debt/EBITDA | 1.43 | ||
| Cap/Depr | 81.01% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | 7.03 | ||
| Cash Conversion | 85.4% | ||
| Profit Quality | 150.76% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.73 |
F-Score6
WACC6.36%
ROIC/WACC1.45
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.6%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.53%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year128.83%
EBIT Next 3Y37.35%
EBIT Next 5Y26.73%
FCF growth 1Y171.85%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y118.83%
OCF growth 3Y101.81%
OCF growth 5Y9.98%
CORBION NV / CRBN.AS FAQ
What is the fundamental rating for CRBN stock?
ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.
Can you provide the valuation status for CORBION NV?
ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.
What is the profitability of CRBN stock?
CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for CRBN stock?
The Price/Earnings (PE) ratio for CORBION NV (CRBN.AS) is 16.31 and the Price/Book (PB) ratio is 1.47.
Can you provide the dividend sustainability for CRBN stock?
The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.19%.